Pharvaris N.V. (PHVS)
NASDAQ·Healthcare·Biotechnology
$34.75
+0.31%
Mkt Cap $2.34B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (27 analysts)
$60.75
Range $42.00 – $79.00
Implied Upside
+74.8%
Consensus $60.75 vs current $34.75
NASDAQ·Healthcare·Biotechnology
$34.75
+0.31%
Mkt Cap $2.34B
Buy
12
Hold
0
Sell
0
Price Target (27 analysts)
$60.75
Range $42.00 – $79.00
+74.8%
Consensus $60.75 vs current $34.75